RNA Competitive landscape Report 2023 by DelveInsight

RNA pipeline constitutes 85+ key companies continuously working towards
developing 100+ RNA treatment therapies, analyzes DelveInsight

Ribonucleic acid (abbreviated RNA) is a nucleic acid present in all living cells that has structural similarities to DNA. Unlike DNA, however, RNA is most often single-stranded. An RNA molecule has a backbone made of alternating phosphate groups and the sugar ribose, rather than the deoxyribose found in DNA.

DelveInsights, "RNA Competitive landscape, 2022," report provides comprehensive insights about 85+ companies and 100+ RNA drugs in the RNA Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Some facts of RNA Competitive landscape report:

• Leading RNA Companies working in the market are Alnylam Pharmaceuticals, Suzhou Ribo Life Sciences, Arrowhead Pharmaceuticals, Sylentis, Vir Biotechnology, Arbutus Biopharma, Silenseed, OliX Pharmaceuticals, Bio-Path Holdings, Janssen Pharmaceuticals, Eli Lilly and Company, Dicerna Pharmaceuticals, Amgen, Sirnaomics, Silence Therapeutics, Sylentis, Aro Biotherapeutics and Others.

• Key RNA therapies in various stages of development include Fitusiran, ARO-APOC3, LY3561774, DCR-HBVS, VIR-2218, Zilebesiran, OLX 101A and Others.

• In November 2021, Arrowhead Pharmaceuticals announced that it entered into an exclusive license agreement with GSK under which GSK will develop and commercialize ARO-HSD.

To know more about the RNA Pipeline Analysis report, click here: RNA Competitive landscape - https://www.delveinsight.com/report-store/rna-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

DelveInsight's RNA Report covers around 100+ products under different phases of clinical development like
• Assessment by RNA Product Type
• Assessment by Stage and Product Type of RNA
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration of RNA
• Assessment by RNA Molecule Type
• Assessment by Stage and Molecule Type of RNA

Emerging RNA Drugs Under Different Phases of Clinical Development Include:

Some of the RNA therapies are Vutrisiran, OLX 101A and Many Others.


Further RNA product details are provided in the report. Download the RNA Pipeline report to learn more about the emerging RNA therapies at: https://www.delveinsight.com/sample-request/rna-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr


Key companies in the RNA Therapeutics Market:

Some of the RNA Companies working in the market are Alnylam Pharmaceuticals, Suzhou Ribo Life Sciences, Arrowhead Pharmaceuticals, Sylentis, Vir Biotechnology, Arbutus Biopharma, Silenseed, OliX Pharmaceuticals, Bio-Path Holdings, Janssen Pharmaceuticals, Eli Lilly and Company, Dicerna Pharmaceuticals, Amgen, Sirnaomics, Silence Therapeutics, Sylentis, Aro Biotherapeutics and Others.

Request for Sample PDF Report to know in detail about the recent developments and advancements in RNA clinical trials - https://www.delveinsight.com/sample-request/rna-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr


Table of Content (TOC)

1. RNA Pipeline Report Introduction
2. RNA Pipeline Report Executive Summary
3. RNA Pipeline: Overview
4. Analytical Perspective In-depth Commercial Assessment
5. RNA Clinical Trial Therapeutics
6. RNA Pipeline: Late Stage Products (Pre-registration)
7. RNA Pipeline: Late Stage Products (Phase III)
8. RNA Pipeline: Mid Stage Products (Phase II)
9. RNA Pipeline: Early Stage Products (Phase I)
10. RNA Pipeline Therapeutic Assessment
11. Inactive Products in the RNA Pipeline
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Key RNA Companies
14. Key Products in the RNA Pipeline
15. Unmet Needs
16. RNA Market Drivers and Barriers
17. Future Perspectives and Conclusion
18. Analyst Views
19. Appendix

Download Sample PDF Report to know more about @ RNA drugs and medication - https://www.delveinsight.com/sample-request/rna-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.